Why Are U.S. Girls Getting Meningococcal But Not Human Papilloma Virus Vaccines? Comparison of Factors Associated with Human Papilloma Virus and Meningococcal Vaccination Among Adolescent Girls 2008 to 2012

Women's Health Issues

Volumn 25, Issue 2, 2015, Pages 97-104

  Perkins, Rebecca B ^a   Lin, Mengyun ^a   Silliman, Rebecca A ^a   Clark, Jack A ^b   Hanchate, Amresh ^c  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; BACTERIUM IDENTIFICATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DATA ANALYSIS; DRUG RESPONSE; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; INFECTION PREVENTION; INTENTION TO TREAT ANALYSIS; NEISSERIA MENINGITIDIS; NONHUMAN; OUTCOME ASSESSMENT; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; SOCIAL ASPECT; TREND STUDY; UNITED STATES; VACCINATION; VACCINE PRODUCTION; VIRUS IDENTIFICATION; WART VIRUS; WOMEN'S HEALTH; AFRICAN AMERICAN; ATTITUDE TO HEALTH; BEHAVIOR; CAUCASIAN; COMPARATIVE STUDY; MENINGOCOCCOSIS; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; PREVENTIVE HEALTH SERVICE; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ADOLESCENT; AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; IMMUNIZATION PROGRAMS; INTENTION; LOGISTIC MODELS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIOECONOMIC FACTORS; UNITED STATES; VACCINATION;

EID: 84924350385     PISSN: 10493867     EISSN: 18784321     Source Type: Journal    
DOI: 10.1016/j.whi.2014.12.005     Document Type: Article

References (52)

1. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices. MMWR Morbidity and Mortality Weekly Report 2007, 56(No RR-2):1-24. Advisory Committee on Immunization Practices (ACIP).
2. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report 2010, 59(20):626-629. Advisory Committee on Immunization Practices (ACIP).
3. Bartlett J.A., Peterson J.A. The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. Journal of School Nursing 2011, 27(6):434-446.
4. Bloom R. Insights on why some girls are skirting the HPV vaccine 2013, Available:, Accessed October 16, 2013. http://commonhealth.wbur.org/2013/10/insights-on-why-some-girls-are-skirting-the-hpv-vaccine?utm_source=cc%26utm_medium=email%26utm_campaign=nwsltr-13-10-16.
5. Boom J.A., Nelson C.S., Laufman L.E., Kohrt A.E., Kozinetz C.A. Improvement in provider immunization knowledge and behaviors following a peer education intervention. Clinical Pediatrics 2007, 46(8):706-717.
6. Brawner B.M., Baker J.L., Voytek C.D., Leader A., Cashman R.R., Silverman R., et al. The development of a culturally relevant, theoretically driven HPV prevention intervention for urban adolescent females and their parents/guardians. Health Promotion Practice 2012, 14:624-636.
7. Brobeck E., Bergh H., Odencrants S., Hildingh C. Primary healthcare nurses' experiences with motivational interviewing in health promotion practice. Journal of Clinical Nursing 2011, 20(23-24):3322-3330.
8. Vaccines for Children Program 2012, Centers for Disease Control and Prevention (CDC), Available:, Accessed December 10, 2012. http://www.cdc.gov/vaccines/programs/vfc/index.html.
9. National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011. MMWR Morbidity and Mortality Weekly Report 2012, 61(34):671-677. Centers for Disease Control and Prevention (CDC).
10. National Immunization Survey-Teen: A user's guide for the 2011 Public-Use Data File 2012, Centers for Disease Control and Prevention (CDC), Available: ftp://ftp.cdc.gov/pub/health_statistics/nchs/dataset_documentation/nis/nisteenpuf11_dug.pdf. Accessed March 14, 2015.
11. Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morbidity and Mortality Weekly Report 2012, 61:258-261. Centers for Disease Control and Prevention (CDC).
12. National and state vaccination coverage among adolescents aged 13-17 years - United States, 2012. MMWR Morbidity and Mortality Weekly Report 2013, 62(34):685-693. Centers for Disease Control and Prevention (CDC).
13. Datasets for the National Immunization Survey - Teen 2013, Centers for Disease Control and Prevention (CDC), Available: http://www.cdc.gov/nchs/nis/data_files_teen.htm. Accessed March 14, 2013.
14. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology 2010, 29(32):4294-4301.
15. Clifford G., Franceschi S., Diaz M., Muñoz N., Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006, 24(Suppl 3):S26-S34.
16. Increasing appropriate vaccination 2014, Community Preventive Services Task Force, Available:, Accessed October 20, 2014. http://www.thecommunityguide.org/vaccines/index.html.
17. Dobson S.R., McNeil S., Dionne M., Dawar M., Ogilvie G., Krajden M., et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: A randomized clinical trial. JAMA 2013, 309(17):1793-1802.
18. Dorell C., Yankey D., Strasser S. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: Teen, 2009. Clinical Pediatrics 2011, 50(12):1116-1124.
19. Dorell C.G., Yankey D., Santibanez T.A., Markowitz L.E. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics 2011, 128(5):830-839.
20. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 2007, 297(8):813-819.
21. Elam-Evans L.D., Yankey D., Jeyarajah J., Singleton J.A., Curtis R.C., MacNeil J., et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2013. MMWR Morbidity and Mortality Weekly Report 2014, 63(29):625-633. Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention (CDC).
22. Gollust S.E., Dempsey A.F., Lantz P.M., Ubel P.A., Fowler E.F. Controversy undermines support for state mandates on the human papillomavirus vaccine. Health Affairs (Millwood) 2010, 29(11):2041-2046.
23. Greco P.J., Eisenberg J.M. Changing physicians' practices. New England Journal of Medicine 1993, 329(17):1271-1273.
24. Grulich A.E., Jin F., Conway E.L., Stein A.N., Hocking J. Cancers attributable to human papillomavirus infection. Sexual Health 2010, 7(3):244-252.
25. Guerry S.L., De Rosa C.J., Markowitz L.E., Walker S., Liddon N., Kerndt P.R., et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011, 29(12):2235-2241.
26. Haber G., Malow R.M., Zimet G.D. The HPV vaccine mandate controversy. Journal of Pediatric and Adolescent Gynecology 2007, 20(6):325-331.
27. Heisler M., Smith D.M., Hayward R.A., Krein S.L., Kerr E.A. Racial disparities in diabetes care processes, outcomes, and treatment intensity. Medical Care 2003, 41(11):1221-1232.
28. Hudson J.L., Miller G.E., Kirby J.B. Explaining racial and ethnic differences in children's use of stimulant medications. Medical Care 2007, 45(11):1068-1075.
29. Jann B. The Blinder-Oaxaca decomposition for linear regression models. Stata Journal 2008, 8(4):453-479.
30. Kempe A., Barrow J., Stokley S., Saville A., Glazner J.E., Suh C., et al. Effectiveness and cost of immunization recall at school-based health centers. Pediatrics 2012, 129(6):e1446-e1452.
31. Klein N.P., Hansen J., Chao C., Velicer C., Emery M., Slezak J., et al. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Archives of Pediatric and Adolescent Medicine 2012, 166(12):1140-1148.
32. Kouyoumdjian F.G., Bailowitz A. Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic. Pediatric Infectious Disease Journal 2011, 30(8):718-719.
33. Kressin N.R., Petersen L.A. Racial differences in the use of invasive cardiovascular procedures: Review of the literature and prescription for future research. Annals of Internal Medicine 2001, 135(5):352-366.
34. Lau M., Lin H., Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Vaccine 2012, 30(20):3112-3118.
35. Leib S., Liberatos P., Edwards K. Pediatricians' experience with and response to parental vaccine safety concerns and vaccine refusals: A survey of Connecticut pediatricians. Public Health Reports 2011, 126(Suppl 2):13-23.
36. Lindley M.C., Smith P.J., Rodewald L.E. Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009. Public Health Reports 2011, 126(Suppl 2):124-134.
37. Litton A.G., Desmond R.A., Gilliland J., Huh W.K., Franklin F.A. Factors associated with intention to vaccinate a daughter against HPV: A statewide survey in Alabama. Journal of Pediatric and Adolescent Gynecology 2011, 24(3):166-171.
38. Markowitz L.E., Hariri S., Lin C., Dunne E.F., Steinau M., McQuillan G., et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. Journal of Infectious Diseases 2013, 208(3):385-393.
39. 50 state summary of meningitis legislation and state laws 2012, National Conference of State Legislatures (NCOSL), Available:, Accessed October 1, 2013. http://www.ncsl.org/issues-research/health/meningitis-state-legislation-and-laws.aspx.
40. National Conference of State Legislatures HPV Vaccine: State legislation 2014, National Conference of State Legislatures (NCOSL), Available:, Accessed August 11, 2014. http://www.ncsl.org/IssuesResearch/Health/HPVVaccineStateLegislation/tabid/14381/Default.aspx.
41. Niccolai L.M., Julian P.J., Meek J.I., McBride V., Hadler J.L., Sosa L.E. Declining rates of high-grade cervical lesions in young women in Connecticut, 2008-2011. Cancer Epidemiology, Biomarkers, & Prevention 2013, 22(8):1446-1450.
42. Omer S.B., Salmon D.A., Orenstein W.A., deHart M.P., Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. New England Journal of Medicine 2009, 360(19):1981-1988.
43. Perkins R.B., Anderson B.L., Gorin S.S., Schulkin J.A. Challenges in cervical cancer prevention: A survey of U.S. obstetrician-gynecologists. American Journal of Preventive Medicine 2013, 45(2):175-181.
44. Perkins R.B., Clark J.A., Apte G., Vercruysse J.L., Sumner J.J., Wall-Haas C.L., et al. Missed opportunities for HPV vaccination in adolescent girls: A qualitative study. Pediatrics 2014, 134(3):e666-e674.
45. Phillips K.A., Morrison K.R., Andersen R., Aday L.A. Understanding the context of healthcare utilization: Assessing environmental and provider-related variables in the behavioral model of utilization. Health Services Research 1998, 33(3 Pt 1):571-596.
46. President's Cancer Panel Annual Report 2012-2013: Accelerating HPV vaccine uptake: Urgency for action to prevent cancer 2014, Presidents Cancer Panel, Available:, Accessed February 24, 2014. http://deainfo.nci.nih.gov/ADVISORY/pcp/annualReports/HPV/index.htm%20-%20sthash.VFWWaxYh.dpbs.
47. Saraiya M., Rosser J.I., Cooper C.P. Cancers that U.S. physicians believe the HPV vaccine prevents: Findings from a physician survey, 2009. Journal of Womens Health (Larchmont) 2012, 21(2):111-117.
48. SEER stat fact sheets: Cervix uteri cancer 2013, Surveillance, Epidemiology, and End Results (SEER), Available:, Accessed November 4, 2013. http://seer.cancer.gov/statfacts/html/cervix.html.
49. Smith P.J., Chu S.Y., Barker L.E. Children who have received no vaccines: Who are they and where do they live?. Pediatrics 2004, 114(1):187-195.
50. Stata statistical software: Release 12 2012, StataCorp, StataCorp LP, College Station, TX.
51. Stokley S., Jeyarajah J., Yankey D., Cano M., Gee J., Roark J., et al. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States. MMWR Morbidity and Mortality Weekly Report 2014, 63(29):620-624. Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC).
52. Suh C.A., Saville A., Daley M.F., Glazner J.E., Barrow J., Stokley S., et al. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics 2012, 129(6):e1437-e1445.